SCHEMBL15327693

SCHEMBL15327693

COC(=O)Oc1sc(C(F)(F)F)cc1O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
DAO P14920 1/20 0.32
CUL4A Q13619 2/20 0.31
NPC1 O15118 1/20 0.31
PKM P14618 1/20 0.31
P2RX1 P51575 1/20 0.30
TMPRSS4 Q9NRS4 1/20 0.30
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
GAA P10253 1/20 0.30
NFKB1 P19838 1/20 0.30
XDH P47989 1/20 0.30
GFER P55789 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6223675 0.86 DAO (0.39) NOTUMHPGDDAONPC1PKM
Hydrochloric Acid SCHEMBL10800905 0.84 CFTR (0.37) NOTUML3MBTL1HPGDTSHRMAPK1
SCHEMBL10805519 0.78 GAA (0.32) NOTUML3MBTL1CUL4ANPC1PKM
SCHEMBL281723 0.73 RAF1 (0.42) NOTUML3MBTL1TSHRNPC1PKM
SCHEMBL10801134 0.72 ALDH1A1 (0.39) L3MBTL1HPGDATMNPC1PKM
SCHEMBL6205872 0.67 HSD17B10 (0.34) L3MBTL1HPGDTSHRCUL4AKDM4E
SCHEMBL6207825 0.65 HSD17B10 (0.33) HPGDTSHRCUL4AKDM4ETDP1
SCHEMBL833851 0.65 DAO (0.46) NOTUMHPGDMAPK1NPSR1DAO
SCHEMBL3672729 0.63 KDM4E (0.37) HPGDTSHRNPC1KDM4ELMNA
SCHEMBL15453564 0.63 CES2 (0.45) NOTUMMAPK1NPSR1P2RX1TMPRSS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599203-B1 1,3-SUBSTITUTED CYCLOALKYL DERIVATIVES CONTAINING ACIDIC, MAINLY HETEROCYCLIC GROUPS, CORRESPONDING PRODUCTION METHOD AND USE OF SAID DERIVATIVES AS MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2013-10-23 EP disclosed